Medication info
Jin Tojet Tablet 10/20 Milligrams

Jin Tojet Tablet 10/20 Milligrams

Prescription medicationTablet
Ingredient · strength
Ezetimibe›10mg / 1 tabletAtorvastatin Calcium Trihydrate›21.7mg / 1 tablet
Manufacturer / importer
Jinyang Pharmaceutical Co., Ltd.
Appearance
White, oblong, film-coated tablet
Packaging
30 tablets/box [10 tablets/PTP packaging (Alu-Alu)x3], 30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202101408 · Approved 2021.02.18 · Insurance code 650304240

Summary

Main use
Improvement of primary and homozygous familial hypercholesterolemia and mixed dyslipidemia
Who uses it
Adults
Adult dosage
This drug is administered once daily without regard to meals. Patients must continue a standard cholesterol-lowering diet before and during treatment with this drug. The dose of this drug should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range of this drug is 10/10mg∼10/80mg once daily. The recommended initial dose is 10/10mg or 10/20mg once daily. For patients requiring a greater reduction in LDL cholesterol (55% or more), the recommended initial dose is 10/40mg once daily. After starting treatment with this drug or titrating the dose, check blood lipid levels at intervals of at least 2 weeks and adjust the dose accordingly. Homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg or 10/80mg once daily. This drug is administered as an adjunct to other lipid-lowering treatments (e.g., LDL-apheresis) or when other lipid-lowering treatments are not useful.

Ingredients

Manufacturer
Jinyang Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary and homozygous familial hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
View approved original text

This medication helps to decrease elevated total cholesterol, LDL-cholesterol, apo B protein, triglycerides, and non-HDL cholesterol levels while increasing HDL cholesterol in patients with primary hypercholesterolemia and mixed dyslipidemia. It is also effective in lowering blood cholesterol in patients with homozygous familial hypercholesterolemia when used alone or in conjunction with other therapies. It is used as a lipid-modifying medication alongside appropriate dietary management for patients at high risk for cardiovascular disease and is also administered as an adjunct when dietary intervention is insufficient. Prior to the use of this medication, it is essential to identify and manage other secondary causes such as diabetes, and hypothyroidism. Regular testing of lipid levels is necessary, and if triglycerides are high, precise management using special testing methods is required. Overall, this medication is an effective treatment for improving blood lipids associated with dyslipidemia.

Dosage and Administration

Adult dosage

This drug is administered once daily without regard to meals. Patients must continue a standard cholesterol-lowering diet before and during treatment with this drug. The dose of this drug should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range of this drug is 10/10mg∼10/80mg once daily. The recommended initial dose is 10/10mg or 10/20mg once daily. For patients requiring a greater reduction in LDL cholesterol (55% or more), the recommended initial dose is 10/40mg once daily. After starting treatment with this drug or titrating the dose, check blood lipid levels at intervals of at least 2 weeks and adjust the dose accordingly. Homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg or 10/80mg once daily. This drug is administered as an adjunct to other lipid-lowering treatments (e.g., LDL-apheresis) or when other lipid-lowering treatments are not useful.

Precautions

This medication poses a risk of serious muscle problems, and treatment should be stopped immediately if acute myopathy or rhabdomyolysis is suspected. It should not be administered to patients with allergies to the active ingredient, severe liver disease, muscle disorders, pregnant or breastfeeding women, or those taking specific other medications. Patients with impaired liver function, alcohol dependence, elderly patients, or those with specific disease histories should use this drug with caution and undergo regular monitoring of liver and muscle conditions. If symptoms such as muscle pain, weakness, fatigue, or fever occur during treatment, the physician should be informed immediately and blood tests should check for muscle damage. Liver function abnormalities may occur, so liver enzyme levels should be monitored before and during treatment, and treatment should be stopped if signs of liver damage appear. This medication should not be used in pregnant women or women who may become pregnant, and fertile women should employ adequate contraception during treatment. There may be symptoms such as dizziness, so caution is needed when driving or operating machinery. Additionally, this medication may interact with several drugs, so patients taking other medications should consult their physician or pharmacist. The safety for pediatric patients has not been established, and it is not recommended for this group, as older patients have an increased risk of muscle-related side effects. In case of overdose, there is no specific antidote, and appropriate treatment and supportive care must be given depending on the symptoms, with monitoring of liver function and muscle enzyme levels. This medication should be stored out of the reach of children, and transferring it to another container should be avoided as it may affect the quality.

Side effects

Muscle pain, abdominal pain, elevated liver enzymes, increased ALT, increased AST, musculoskeletal pain, dizziness, cough, nausea, joint pain, muscle weakness, hyperkalemia, bronchitis, sinusitis, flushing, headache, fatigue, constipation, diarrhea, vomiting, belching, pancreatitis, pharyngeal and laryngeal pain, nosebleed, insomnia, nightmares, sensory disturbances, sensory loss, taste disturbances, memory loss, peripheral neuropathy, muscle cramps, joint swelling, back pain, neck pain, muscle fatigue, complications due to rupture, myopathy, myositis, rhabdomyolysis, tendon disorders, muscle rupture, lupus-like syndrome, immune-mediated necrotizing myopathy, thrombocytopenia, allergic reactions, anaphylaxis, hepatitis, cholestasis, liver failure, blurred vision, visual impairment, tinnitus, hearing loss, urticaria, skin rash, itching, hair loss, angioedema, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, gynecomastia, increased serum creatine kinase, positive urinary leukocytes, nightmares, vomiting, abdominal abnormalities, cholelithiasis, cholecystitis, drug-induced liver injury, eosinophilia, systemic symptoms associated drug reactions, erythema multiforme, fatigue, chest discomfort, asthenia, generalized edema, diabetic neuropathy, tremors, epigastric pain, gastritis, dry mouth, epigastric discomfort, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, sputum, anemia, splenomegaly, urticaria, hyperhidrosis, rash, itching, upper respiratory infection, conjunctival hyperemia, renal failure, liver dysfunction, increased serum creatinine, elevated blood pressure, increased blood urea, elevated CPK, abnormal liver function tests, anaphylaxis, urticaria, rash, vascular edema, joint pain, muscle pain, increased creatine phosphokinase levels, myopathy, rhabdomyolysis, elevated liver aminotransferase levels, hepatitis, abdominal pain, thrombocytopenia, nausea, pancreatitis, dizziness, sensory disturbances, depression, headache, cholelithiasis, cholecystitis, drug-induced liver injury, Stevens-Johnson syndrome, toxic epidermal necrolysis, eosinophilia, systemic symptoms associated drug reactions, erythema multiforme

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is best to maintain a storage temperature between 1 degree and 30 degrees at room temperature. By doing this, the effectiveness of the medication can be safely preserved.

Appearance and packaging

Appearance

White, oblong, film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP packaging (Alu-Alu)x3], 30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.